You are viewing the site in preview mode

Skip to main content

Table 3 Laboratory tests of the patients treated for acute cholecystitis during the COVID-19 pandemic comparing those who survived (n = 2482) and those who died (n = 64)

From: COVID-19 infection is a significant risk factor for death in patients presenting with acute cholecystitis: a secondary analysis of the ChoCO-W cohort study

Variable

Alive, n = 2482

Dead, n = 64

p

WBC count/ mm3

7540 (18,430)

8156 (8266)

0.06

C Reactive Protein mg/L

80.66 (111.8)

152 (149.3)

 < 0.001

 AST U/L value

90.2 (171)

104.2 (147.3)

0.004

 ALT U/Lvalue

95.7 (150)

88 (107.2)

0.22

 Total bilirubin mg/dL

5.38 (26)

9.21 (20.1)

0.08

Lactate mmol/L

15.82 (76.4)

19.5 (70.7)

 < 0.001

 Prothombinetime time sec

18.1 (20.5)

16.4 (12.2)

0.013

 APTT sec

26.6 (11.4)

31.19 (14.5)

0.007

  1. WBC white blood cell count; AST aspartate aminotransferase; ALT alanine aminotransferase; APTT activated partial thromboplastin time